(Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | (FY)Jul 31, 2022 | (Q4)Jul 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -99.88%-361.83K | 70.28%-247.44K | 96.97%-28.13K | -218.11%-2.06M | 86.65%-113.83K | 93.13%-181.02K | 69.40%-832.59K | -116.70%-929.08K | -5,191.27%-646.49K | -4,737,077.78%-852.69K |
Net income from continuing operations | 107.18%203.86K | 108.33%504.11K | 112.61%296.27K | -4.01%-12.55M | 75.52%-1.31M | 68.46%-2.84M | -72.93%-6.05M | -140.71%-2.35M | -22,871.09%-12.06M | -39,273.62%-5.33M |
Operating gains losses | ---- | ---- | ---- | -41.26%215.46K | -118.98%-145.54K | 4,052.71%360.66K | 91.80%-86 | 100.10%417 | --366.82K | --766.62K |
Depreciation and amortization | -63.31%40.64K | -95.08%6.27K | -83.51%20.44K | 66.93%402.89K | -63.56%40.84K | 54.10%110.79K | 123.27%127.3K | 32,436.48%123.96K | --241.36K | --112.07K |
Asset impairment expenditure | --0 | ---- | ---- | 60.85%6.6M | -70.35%1.22M | --1.9M | ---- | ---- | --4.1M | --4.1M |
Remuneration paid in stock | -86.90%16.11K | -110.34%-122.53K | -92.00%88.4K | -57.01%2.57M | -82.28%153.49K | -97.51%123.03K | 761.18%1.18M | 4,247.93%1.11M | --5.97M | --866.25K |
Deferred tax | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---1.26M | ---- |
Other non cashItems | -353.91%-150.14K | -41.00%24.66K | -83.93%16.68K | -89.23%213.79K | 105.36%9.05K | -92.44%59.13K | -95.31%41.79K | -78.36%103.81K | --1.98M | ---168.85K |
Change In working capital | -614.94%-558.76K | -251.72%-573.5K | -620.06%-449.92K | 4,634.61%489.56K | -236.67%-83.45K | -80.67%108.51K | 223.73%377.99K | 128.23%86.51K | -74.34%10.34K | 351.51%61.06K |
-Change in receivables | -161.26%-41.12K | -109.14%-3.85K | -175.02%-6.34K | 148.91%104.92K | 40.76%-12.82K | 157.53%67.11K | 169.91%42.18K | 153.21%8.46K | ---214.52K | ---21.65K |
-Change in prepaid assets | 100.62%48.74K | 77.64%-7.1K | -75.87%13.36K | 185.13%261.43K | 15.69%213.53K | -28.00%24.29K | 90.43%-31.76K | 128.63%55.37K | ---307.08K | --184.57K |
-Change in payables and accrued expense | -167.89%-11.61K | -102.24%-8.22K | 404.58%98.28K | -19.01%493.06K | 187.28%88.91K | -97.63%17.1K | 323.17%367.57K | 120.03%19.48K | 1,411.00%608.78K | -853.26%-101.86K |
-Change in other working capital | -27,738,450.00%-554.77K | ---554.32K | -17,364.09%-555.21K | -381.33%-369.85K | -5,329,371.43%-373.06K | --2 | --0 | --3.22K | ---76.84K | ---7 |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -99.88%-361.83K | 70.28%-247.44K | 96.97%-28.13K | -218.11%-2.06M | 86.65%-113.83K | 93.13%-181.02K | 69.40%-832.59K | -116.70%-929.08K | -5,191.26%-646.49K | -4,737,072.22%-852.69K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 0 | 0 | 112.23%352.85K | 110.30%34.97K | 99.90%-1.62K | 89.25%-107.1K | 284.76%426.6K | -2.89M | -339.71K |
Net PPE purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---412.84K | --66.14K |
Net intangibles purchas and sale | --0 | --0 | --0 | 75.58%-451.34K | 108.62%34.97K | 99.89%-1.35K | 48.00%-107.1K | ---377.86K | ---1.85M | ---405.84K |
Net business purchase and sale | --0 | --0 | --0 | 256.53%804.19K | --0 | ---268 | --0 | 256.65%804.46K | --225.56K | --0 |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---850.54K | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | --0 | --0 | 112.23%352.85K | 110.30%34.97K | 99.90%-1.62K | 89.25%-107.1K | 284.76%426.6K | ---2.89M | ---339.71K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 11.45%-27.5K | -15.67%903.5K | -87.84%47K | -61.55%1.48M | 218.33%57.26K | -367.34%-31.06K | -55.58%1.07M | -73.98%386.45K | 3.86M | -48.38K |
Net issuance payments of debt | -173.70%-85K | -108.55%-62K | -96.89%12K | 686.20%1.14M | 218.33%57.26K | 35.81%-31.06K | 2,349.31%725.54K | 693.26%385.62K | ---194.02K | ---48.38K |
Net common stock issuance | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --3.99M | --0 |
Proceeds from stock option exercised by employees | 5,750,100.00%57.5K | --0 | --0 | 477.78%346.67K | --0 | -100.00%-1 | --345.83K | --833 | --60K | --0 |
Net other financing activities | ---- | ---- | --35K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 11.45%-27.5K | -15.67%903.5K | -87.84%47K | -61.55%1.48M | 218.33%57.26K | -367.34%-31.06K | -55.58%1.07M | -73.98%386.45K | --3.86M | ---48.38K |
Net cash flow | ||||||||||
Beginning cash position | 155.74%721.91K | -65.85%65.85K | -84.75%46.98K | 12,514.05%308.04K | -95.63%68.59K | -95.18%282.28K | -97.31%192.84K | 12,514.05%308.04K | -83.34%2.44K | 63,754.15%1.57M |
Current changes in cash | -82.18%-389.33K | 398.23%656.06K | 116.27%18.87K | -167.05%-219.65K | 98.26%-21.6K | 95.01%-213.7K | 110.09%131.68K | -101.62%-116.03K | 2,781.21%327.59K | -6,893,122.22%-1.24M |
Effect of exchange rate changes | --0 | --0 | --0 | -88.22%-41.4K | 99.98%-4 | --2 | ---42.23K | --833 | ---22K | ---22K |
End cash Position | 384.92%332.58K | 155.74%721.91K | -65.85%65.85K | -84.75%46.98K | -84.75%46.98K | -95.63%68.59K | -95.18%282.28K | -97.31%192.84K | 12,514.05%308.04K | 12,514.05%308.04K |
Free cash from | -98.40%-361.83K | 73.67%-247.44K | 97.85%-28.13K | 16.41%-2.51M | 93.86%-78.86K | 95.76%-182.38K | 68.32%-939.7K | -123.56%-1.31M | -24,455.33%-3M | -7,139,122.22%-1.29M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data